Conversational agents are taking on scheduling, intake, and follow-ups, whereas clinics assess whether automation can ease ...

Global pediatric data suggest resistance to last-line antibiotics is climbing fast, with ICU and sepsis cases showing some of ...

While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable ...

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood ...

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated ...

Adding waist-based central obesity measures to BMI may improve the identification of risk for multimorbidity in adults with ...

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

A novel spectacle lens design featuring aspherical lenslets reduced myopia progression in children by more than 70% compared with standard single-vision lenses over 24 months.

A reanalysis of lecanemab and donanemab trials suggests cognitive decline accelerates in open-label extensions, matching placebo rates, and challenging claims that cognitive benefits increase over ...

Using targeted therapy for spondyloarthritis for more than 6 months per year is not associated with an increased risk for cancer compared with using targeted therapy for shorter durations.

Researchers applied the physics of the instrument to a new device that reproduces the heart’s complex blood flow waveforms.

Real-world data revealed a high level of effectiveness on par with clinical trial data even among a high-risk population.